Tal David and Amit Ben Kish: The Singularity is Here in Parallels with Quantum Art

Tal David and Amit Ben Kish: The Singularity is Here in Parallels with Quantum Art

The Quantum Revolution: A Paradigm Shift for AI Synergy Tal David and Amit Ben Kish, founders of Quantum Art, describe quantum computing not merely as an upgrade to existing software, but as a fundamental hardware paradigm shift. While AI remains a software revolution running on traditional CPUs and GPUs, quantum computing utilizes Quantum Processing Units (QPUs) to solve problems with a completely different logic. Tal highlights three massive implications of this technology: accelerating specific AI workloads by factors of a million or more, drastically reducing energy consumption compared to current AI data centers, and creating a “two-way street” where AI helps design more complex quantum systems. Amit emphasizes that their trapped-ion architecture allows for exponential memory and computational space, enabling calculations—such as complex chemical reactions—that are physically impossible for classical computers to store or process. The company is focused on the intense capital and engineering effort required to integrate optics, vacuum systems, and quantum physics into a commercially viable product. Ions and Multi-Qubit Gates: A Quantum Mosaic Quantum Art’s technical strategy centers on the use of trapped ions, which Amit describes as “nature’s perfect qubits.” Unlike superconducting modalities that require cooling entire massive fridges to near absolute zero, Quantum Art uses lasers to cool only the ions themselves, significantly increasing efficiency. To overcome the inherent noise in quantum systems, the team employs a “logical qubit” approach, bunching physical qubits together to fix errors faster than they occur. Their unique architecture utilizes multi-qubit gates—“beasts” capable of performing thousands of operations in a single step—and a reconfigurable “Quantum FPGA” design that allows them to compress complex circuits into a tiny physical footprint. The Advantage of Quantum-AI Symbiosis: 2027 and Beyond Tal outlines two critical milestones for the industry: the “Quantum Advantage” moment and “Utility Scale.” Quantum advantage—the point where a quantum computer surpasses the world’s most powerful supercomputers on commercially relevant problems—is expected as early as late 2027 or 2028. This requires roughly 50 to 100 noiseless, logical qubits. The broader utility scale, involving systems with a million qubits capable of unlocking the technology’s full potential, is projected for the mid-next decade. Hybrid quantum-classical AI data centers are expected to consume orders of magnitude less energy than today’s AI data centers. Tal notes that this shift could eliminate the need for energy-intensive solutions like nuclear-powered data centers, making quantum computing a cornerstone of sustainable technology. While the hardware will likely remain in data centers rather than iPhones, Tal notes that “Quantum as a Service” already allows users to access this power via the cloud. Lights, Camera, Quantum: From Drug Discovery to Digital Art The versatility of quantum computing allows mathematical solutions in one field to migrate seamlessly to others. Tal explains how solving the wave equation for telecommunications—analyzing signal propagation through buildings—can be mapped directly onto computer animation to simulate ocean waves with extreme precision. The technology is poised to disrupt pharma through high-complexity molecular modeling, finance through fraud detection, and logistics through traffic optimization. By using sophisticated compilers and transpilers, Quantum Art aims to make this transition invisible to the end-user, providing a software-like experience backed by quantum hardware. Building a World-Class Infrastructure on a Nobel Foundation The genesis of Quantum Art is rooted in elite academia and deep-tech experience. Amit reflects on his time working at NIST Boulder with Nobel laureate Dave Wineland, whose “Bible” of quantum processes laid the groundwork for the industry twenty-five years ago. Spun out of the Weizmann Institute in 2022, Quantum Art has rapidly scaled to a team of over 60 specialists from institutions like Stanford and Harvard, as well as industry giants like Intel and Google. The New York Stock Exchange foreshadowed their future with an honorable mention after raising a record-breaking $140 million Series A. Testing the Waters: The Temperature is Right Tal concludes that quantum computing is no longer science fiction; it is an approaching reality that requires a “paradigm shift” in organizational thinking. He notes that most Fortune 500 companies are already “testing the temperature” by developing applications today. His advice to technological organizations is direct: “get your hands dirty” by using simulators and working with hardware providers now to prepare for the imminent quantum revolution. Get full access to Seantzu at seantzu.substack.com/subscribe [https://seantzu.substack.com/subscribe?utm_medium=podcast&utm_campaign=CTA_4]

Edwin Mata: Diamonds are a Token's Best Friend but Royalties are Forever

Revolutionizing Asset Tokenization: Simplicity, Speed, and Structure Edwin Mata demystifies tokenization as the process of transforming real-world assets—such as real estate, equities, intellectual property, and luxury goods—into digital tokens that can be divided, distributed, and settled on a blockchain. Brickken’s platform streamlines the traditionally complex and bureaucratic world of securitization, enabling capital formation with unprecedented speed and efficiency. Crucially, Edwin emphasizes that tokenization is not a regulatory loophole; it is an efficiency layer that operates strictly within existing legal frameworks. “If something is not legal to be securitized or offered to the public, then it won’t be tokenized,” he asserts. Brickken’s technology accelerates compliant processes, offering features like T+0 settlement and one-click dividend distribution. The Power of Intangible Assets: IP, Royalties, and Entertainment Brickken’s mission extends beyond tangible assets to the world of intangibles—intellectual property, royalties, music licensing, film rights, and event access. Edwin explains how tokenization empowers creators—musicians, filmmakers, and artists—to monetize their work and unlock new revenue streams, all while maintaining control and compliance. He highlights the challenges of navigating complex legal frameworks, such as sync licensing in music or FIFA’s strict IP rules for athletes. Brickken’s adaptable technology ensures that each asset’s unique legal structure is respected, empowering creators without overstepping regulatory boundaries. Bridging the Gap Between Technology and Regulation Compliance is at the heart of Brickken’s approach. Edwin details how the platform integrates Know Your Customer (KYC) protocols and accreditation checks to ensure offerings meet local securities laws. In the U.S., Brickken’s system enforces regulatory guardrails—blocking non-accredited investors and tailoring processes to frameworks like Regulation D. In Europe, the platform aligns with MiFID II and adapts to country-specific requirements. “We format the technology for you to be compliant under the regulation that you’re trying to enact,” Edwin explains, positioning Brickken as both an innovation engine and a compliance backbone. Tokenization Across All Asset Classes: From Diamond Rings to Biotech Startups Brickken is redefining investor access to a diverse array of asset classes—from Picasso paintings and diamond rings to biotech startups and film productions. Tokenization democratizes access to previously illiquid markets, allowing investors to participate in short-term, high-yield opportunities once reserved for institutions. Edwin notes, however, that investor appetite often favors short-duration, high-liquidity, high-yield instruments—a reflection of Web3’s culture of instant liquidity. Successfully blending these expectations with the realities of real-world assets requires careful calibration and robust corporate governance, ensuring legal authority is established before tokenization proceeds. Valuation, Trust, and the Role of Certified Partners Trust and transparency are central to Brickken’s model. The platform offers best-practice valuation guidance and connects issuers with certified valuation partners worldwide. These assessments can be embedded directly into smart contracts, creating a verifiable trust link between an asset’s value and what investors purchase. This is especially vital for early-stage or independent issuers who may lack established financial histories. While Brickken is not an auditor, its network of partners ensures credibility and rigor for every offering. The Derivatives Dilemma: Why Real-World Assets Are Not Digital-Native Edwin addresses the complexities of creating derivatives for tokenized real-world assets. Unlike digital assets or commodities with real-time valuation and deep liquidity, real-world assets—like art or private equity—lack 24/7 valuation infrastructure. Attempting to create derivatives in such markets risks generating “fake markets” and destabilizing early participants. Edwin cautions against treating real-world assets as digital-native, emphasizing the need for robust market makers, liquidity providers, and real-time data before derivatives can safely flourish in this space. The Future of Tokenized Ecosystems: AI, Real-Time Valuation, and Mass Digitization Looking forward, Edwin envisions artificial intelligence as a game-changer for real-time asset valuation. AI agents could continuously scan financial data and provide live valuation signals, unlocking the full potential of tokenized ecosystems. However, he warns that continuous information flow is a double-edged sword—real-time exposure could destabilize smaller companies not ready for public scrutiny. The goal is to balance transparency and efficiency with the stability needed for early-stage issuers to thrive. A Vision for the Future: The Great Digitization Edwin predicts a sweeping shift toward the mass digitization of private markets over the next decade. The trillions locked in illiquid asset classes—luxury goods, private credit, entertainment IP, biotech, fine art—represent vast untapped value. Brickken aims to be the infrastructure that unlocks this potential. “Even this incipient market might take five to ten years,” Edwin says, “but in the future, all will be digitized. We’re heading toward a mass digitization where there’s going to be a lot of value extracted from private, previously inaccessible markets—and I think we are really going to be living in an incredibly exciting world in the next ten years.” Get full access to Seantzu at seantzu.substack.com/subscribe [https://seantzu.substack.com/subscribe?utm_medium=podcast&utm_campaign=CTA_4]

Eze Abosi: Backed by Novartis to Feed Your Head with AI Drug Development

Visionary Leadership in Life Sciences Eze Abosi is a trailblazer in the life sciences industry, leveraging over 20 years of expertise in healthcare, data analytics, and consulting to reshape how clinical and genomic data are utilized to improve patient care. As the Chief Growth Officer at Holmusk, a Series B-stage medical technology company backed by Novartis, Abosi leads sales, marketing, and service functions, driving the company’s mission to redefine neuropsychiatry and neuroscience research. Under his leadership, Holmusk has become a critical player in the integration of clinical and genomic data, empowering researchers, healthcare providers, and biopharma companies to address the most complex challenges in healthcare. Psychedelics: A New Dimension in Mental Health Abosi and Holmusk are at the cutting edge of psychedelic drug development, a burgeoning field that promises to revolutionize the treatment of mental health disorders. As the U.S. FDA and other global regulators begin to fast-track the approval of psychedelic therapies, Holmusk plays a critical role by providing enriched datasets that help biotech companies like Compass Pathways and Atai Life Sciences advance their clinical trials. Abosi highlights the transformative potential of psychedelics, such as psilocybin and MDMA, in treating mental health conditions like depression and anxiety. With a focus on data enrichment, Holmusk supports these organizations by creating high-quality evidence to showcase the efficacy and safety of psychedelic therapies. “The lack of significant side effects in psychedelics, compared to traditional treatments like benzodiazepines, makes them a game-changer for patients,” Abosi explains. Holmusk is also helping to bridge the gap between hallucinogenic properties and therapeutic benefits by supporting research into second-generation psychedelics that isolate medicinal properties while minimizing hallucinogenic effects. AI Drug Development: Accelerating Discovery with Data Artificial intelligence in drug development is one of the most exciting and challenging frontiers in healthcare, and Abosi is positioning Holmusk at its forefront. By integrating high-quality, curated clinical data with cutting-edge machine learning techniques, Holmusk enables biopharma companies to de-risk the critical early stages of drug discovery and clinical research. Abosi explains that Holmusk’s datasets are particularly valuable for AI applications that aim to characterize patient populations and identify underserved subgroups. This capability is especially relevant in central nervous system (CNS) disorders, where Holmusk’s enriched datasets allow researchers to stratify patients by symptoms and develop therapies targeted at specific subpopulations, such as acute anxiety or treatment-resistant depression. Despite the potential of AI in drug development, Abosi notes that progress has been relatively slow, often stalling at Phase 2 trials. However, Holmusk is working to change that by fostering collaborations with researchers and biotech firms to accelerate the application of AI in clinical trials and commercialization. “AI is only as good as the data it’s applied to,” Abosi says. “Our role is to ensure that the data is robust, enriched, and capable of driving breakthroughs in drug development.” Pioneering the Intersection of Physical and Mental Health One of Holmusk’s most groundbreaking achievements lies in its ability to link physical and mental health outcomes through data. Abosi points to collaborations with institutions like Oxford University and Stanford’s Bioinformatics Department as examples of how Holmusk is breaking down silos in healthcare. A notable study conducted in partnership with Oxford explored correlations between GLP-1 medications (commonly used for cardiometabolic conditions) and mental health outcomes. Holmusk’s enriched datasets revealed meaningful insights into how these medications not only improve physical health but also impact cognitive function and mental health disorders like anxiety and depression. “This research represents the holy grail of healthcare,” Abosi says. “By looking at the patient holistically, we can establish critical links between physical and brain health.” The Skinny on GLP-1: Redefining Drug Market Access Beyond research and development, Abosi is driving innovation in how drugs are commercialized and accessed. Holmusk collaborates with payers, pharma companies, and healthcare providers to create robust economic stories for new therapies. This is particularly critical in CNS disorders, where traditional approaches to drug development and commercialization often fall short. For example, Holmusk helps manufacturers demonstrate the economic value of their therapies by showing how premium-priced medications can reduce overall healthcare costs. Abosi provides the example of GLP-1 medications: although more expensive than generics like Metformin, GLP-1s have been shown to reduce long-term healthcare costs by improving both physical and mental health outcomes. “Our data enables manufacturers to create compelling value stories that secure better formulary placements and ultimately improve access for patients,” Abosi explains. Driving Innovation in Neuropsychiatry and Neuroscience Holmusk’s mission extends beyond supporting biopharma companies—it aims to elevate the entire field of neuropsychiatry and neuroscience to the same level of precision and rigor seen in other therapeutic areas like oncology or cardiology. By enriching datasets with behavioral, clinical, and genomic information, Holmusk enables researchers to better understand the full scope of CNS disorders and develop targeted interventions that address unmet needs. Abosi also emphasizes the role of Holmusk in fostering collaborations between academic institutions, healthcare providers, and biopharma companies. These partnerships are critical for advancing research in complex areas like schizophrenia, bipolar disorder, and substance use disorders, where traditional data sources often fall short. A Vision for the Future Eze Abosi’s work at Holmusk represents a bold vision for the future of healthcare. By integrating cutting-edge technologies like AI, advancing psychedelic drug development, and breaking down silos between physical and mental health, Abosi is reshaping how the life sciences industry approaches patient care. “What excites me most is the potential to create a better healthcare ecosystem—one that looks at the patient holistically and leverages data to drive innovation,” Abosi says. With his leadership, Holmusk is not only advancing the field of neuropsychiatry but also setting a new standard for how data and technology can transform healthcare as a whole. Through his relentless focus on data, collaboration, and innovation, Eze Abosi is proving that the future of healthcare lies at the intersection of science, technology, and human-centered care. Get full access to Seantzu at seantzu.substack.com/subscribe [https://seantzu.substack.com/subscribe?utm_medium=podcast&utm_campaign=CTA_4]

Aron D’Souza: The Enhanced Game of Hulk Hogan vs. Gawker and Birth of Objection AI

Aron D’Souza is not just a founder—he’s a visionary disruptor. From masterminding the revolutionary Hulk Hogan vs. Gawker lawsuit that redefined accountability in the media, to creating Objection AI, a groundbreaking truth arbitration platform, D’Souza’s career has been defined by audacity and relentless ambition. In this episode, he shares his journey of challenging societal norms and reshaping industries, offering a masterclass in leadership, innovation, and the art of building transformative ventures. The Gawker Lawsuit: A Blueprint for Accountability Aron D’Souza’s rise to prominence began with a chance encounter at Oxford University in 2009, where he met Peter Thiel, the legendary venture capitalist and investor in Facebook, Spotify, and Palantir. What started as a casual conversation about media accountability turned into a five-year, $10 million legal crusade that culminated in a $140 million judgment for Hulk Hogan and the bankruptcy of Gawker Media. D’Souza reflects on the pivotal moment when he proposed his idea to Thiel: “I probably said the most important words of my life—‘If you don’t want to sue them, why don’t you find someone who wants to, but doesn’t have the financial resources to do so?’” The rest is history. The case, which remains one of the most consequential media lawsuits in American history, demonstrated the power of strategy, resilience, and focus. Now, D’Souza is taking the lessons from that legal battle and applying them to his latest venture, Objection AI, compressing the time and cost of holding media outlets accountable from years and millions of dollars to just weeks and a fraction of the price. Objection AI: The Court for the Internet With Objection AI, D’Souza is tackling one of the most pressing issues of the digital age: the absence of a reliable truth arbitration system for the internet. This revolutionary platform allows individuals to challenge misinformation and media bias using a process inspired by both the judiciary and the scientific method. For as little as $2,000, Objection AI’s team of investigators—comprised of former CIA and FBI agents—analyzes media claims, compiles evidence, and creates a public data room for transparency. The journalist or media outlet in question is invited to respond, creating an adversarial process that mirrors a court of law. “Truth isn’t a vibe; truth is a process,” D’Souza asserts. He explains how the platform leverages both human expertise and AI to ensure rigorous truth-seeking. “The internet doesn’t have a native truth adjudication layer. Anyone can write anything, and it’s incredibly difficult to challenge false information. Objection AI changes that.” With a long-term vision of becoming “the court for everything,” Objection AI is poised to replace the judiciary’s slow-moving processes with an efficient, scalable alternative. “Even the wealthiest individuals can struggle to access justice in today’s legal system,” D’Souza notes. “We’re building a platform where truth is accessible to everyone.” The Enhanced Games: Superhuman Achievement Redefined D’Souza’s ambition doesn’t stop at media accountability. As the president of the Enhanced Games, a $2.5 billion company poised to go public and challenge the Olympics, he’s redefining the limits of human potential. The Enhanced Games embraces performance-enhancing technologies under medical supervision, positioning itself as a bold alternative to traditional sports competitions. “The Olympics celebrates outdated ideals,” D’Souza says. “The Enhanced Games is about celebrating the future—pushing the boundaries of what humanity can achieve.” Guided by a scientific advisory board that includes luminaries like George Church, the world-renowned geneticist and co-founder of Colossal Biosciences, the Enhanced Games is breaking new ground in both sports and science. D’Souza credits Church’s involvement as pivotal, explaining how he cold-emailed the Harvard professor with his vision: “He didn’t even need the pitch. He just said, ‘I’m in. Let’s get to work.’” Together, they’ve developed groundbreaking protocols for enhancing athletes, turning the Enhanced Games into a global platform for superhuman innovation. Leadership Lessons from Rugby and Startups D’Souza’s leadership style is deeply influenced by his time playing rugby at Oxford. “Rugby is simple—you have a unified goal: to win,” he says. This clarity of purpose has carried over into his ventures. Whether it’s the Enhanced Games or Objection AI, D’Souza emphasizes the importance of focus and mission-driven leadership. “Every great business feels a little bit dangerous,” he reflects. “Airbnb, Uber, OpenAI—they all started by challenging entrenched systems. The same is true for Objection AI and the Enhanced Games.” Having founded 12 startups with five successful exits, D’Souza has learned that talent is the most critical ingredient for success. “Strategy and capital are commodities,” he explains. “What sets a great company apart is its ability to attract top-tier talent. And that comes down to mission. People want to work on something that matters.” Cold Emails, Bold Moves, and the Hollywood Connection D’Souza’s career is a testament to the power of boldness. From cold-emailing billionaires and Harvard professors to pitching Peter Thiel in his first week at Oxford, he’s never been afraid to take risks. “You can literally do anything,” he insists. “A lot of people just sit there waiting for opportunities to come to them. But you can make your own destiny.” This audacity extends to Hollywood, where the Hulk Hogan vs. Gawker story is being adapted into a feature film, with Matt Damon and Ben Affleck rumored to star. “Hollywood moves at a snail’s pace compared to Silicon Valley,” D’Souza jokes. “In the time it takes them to make a movie, we can build a unicorn.” A Legacy of Disruption and Impact From toppling media empires to pioneering truth arbitration and superhuman athletics, Aron D’Souza’s career is defined by fearless innovation and a refusal to accept the status quo. Whether he’s challenging the judiciary, reimagining competitive sports, or creating new systems of accountability, D’Souza is driven by a singular mission: to build a better world through bold, transformative ideas. “Every great business feels a little bit dangerous,” he says. “That’s how you know you’re onto something big.” In this episode, discover how Aron D’Souza is challenging the status quo—and winning. Get full access to Seantzu at seantzu.substack.com/subscribe [https://seantzu.substack.com/subscribe?utm_medium=podcast&utm_campaign=CTA_4]

Ben Narasin: The Tenacity of Zenefits and Giving Lady Gaga a Boardseat

From Teenage Hustler to Dot-Com Pioneer Ben Narasin’s journey is a testament to reinvention and resilience. From his early days as a 12-year-old hustler with entrepreneurial ambitions to becoming the founder of Tenacity Venture Capital, Narasin’s path is marked by conviction, adaptability, and a deep empathy for founders. By his teens, he was already innovating and finding ways to make money, but it was the launch of Fashionmall.com in 1993 that set him apart. Envisioning a future where fashion and the internet would intersect, Narasin led Fashionmall.com to become one of the first e-commerce companies to go public in 1999. When the dot-com bubble burst, he made the rare founder-first decision to take the company private, ensuring liquidity for all stakeholders and demonstrating his commitment to doing what’s right, even in turbulent times. Reflecting on his journey, Narasin notes, “Long journey, lots of overnight successes in the world that take decades.” After establishing himself on the East Coast, he moved to Silicon Valley, drawn by its unique entrepreneurial culture. Trading the title of CEO for that of venture capitalist, Narasin joined TriplePoint Ventures, Canvas Ventures, and later NEA, one of the world’s largest VC firms. Despite the shift, he remained an entrepreneur at heart, living vicariously through the founders he backed. This founder empathy became his superpower, enabling him to identify and nurture talent that would shape the future of technology. Me, Myself, and I: The Solo GP Life As a solo General Partner, Narasin injects humor and candor into his work. “I argue with myself all the time. People often ask, where’s your team? Well, I say, it’s right here. All three of us are here. Me, myself, and I.” This independence allows him to scrutinize his own decisions, constantly challenging his assumptions and refining his approach. “One of the nice things about being a solo GP is you only have yourself to answer to, for the most part. I mean, truth is the ultimate defense.” Narasin is known for his extreme selectivity, reviewing 10,000 pitches in two years but funding only six. In the previous year, he made just one investment out of thousands of pitches. His performance metrics are exceptional: a 13X MOIC, 97% IRR, and a 63–74% Seed-to-Series A progression rate. “I’m a bit overly neurotic and picky,” he admits. “Even with that, about a third of the companies don’t make it. So, you know, there is no such thing as a sure thing.” His portfolio includes standout companies like Dropcam, Lending Club, Zenefits, TellApart, Kabbage, and Vungle, underscoring his ability to back exceptional founders. Wining About Noble Prizes and EGOT Awards: Hard and Soft Skills on the Palette Drawing vivid analogies between Nobel Prizes and EGOT awards to illustrate the balance between hard and soft skills in entrepreneurship illustrates a dichotomy of skills. Nobel Prizes, which can be sold for millions, symbolize technical expertise and deep innovation—the backbone of foundational companies. In contrast, EGOT awards (Emmy, Grammy, Oscar, Tony) represent charisma, storytelling, and the ability to connect emotionally—skills critical for building relationships and inspiring teams, even if their resale value is capped. Both skill sets are essential for long-term success. CrossFit and Scaling Startups: Pukey the Clown vs. Uncle Rhabdo To describe the relentless demands of entrepreneurship, Narasin often uses CrossFit metaphors. “Startups demand everything,” he explains. “There’s no room for work-life balance. If you’re not collapsed on the floor at the end of the day, panting for breath, you probably haven’t put in enough effort.” He likens entrepreneurship to intense physical training, where resilience, discipline, and the ability to endure setbacks are crucial. Narasin also emphasizes the role of luck and timing: “You have to be smart, you have to work hard, but you will need some luck along the way. And the harder you work, the luckier you’ll be.” His IPO journey, where every day and decision mattered, reinforced the importance of relentless effort. Celebrity Capital: The Art of Authenticity Narasin offers a nuanced perspective on celebrity involvement in venture capital. He recalls initial skepticism about Ashton Kutcher’s entry into startup investing but came to respect Kutcher’s commitment and the strong team he built. Similarly, he questions the value of celebrity-led investment rounds, noting that true impact requires time, expertise, and dedication. “There are people that have made tremendous amounts of money investing in startups, and if being the celebrity that they are gets them access... there are a finite amount of things a successful investor has to do and do well, and they’re very time-consuming, they’re very hard.” For Narasin, authenticity and a willingness to roll up one’s sleeves matter far more than fame. * On Ashton Kutcher: “I remember when Ashton first came onto the scene, I ran into him at Y Combinator, had to be 15 plus years ago, and I remember being sort of quizzical. I’m not really a... first of all, I’m not into any sport, and I’m not really into celebrities, but I was like, huh, so I went over and said, what are you doing here? And he said, oh, I, you know, I’m interested in getting into some of the startup investing. And I remember thinking, Well...” * On Lady Gaga: “She said, Lady Gaga wants to invest. I was like, okay. She said, actually, she wants to lead the round. And I remember saying, why does that help you? Like, what is the chance Lady Gaga will have time to help you when you need help? ... But the idea of being a lead was something I was quizzical about, because that takes a very specific and rigorous set of realities that you want to do to create the right documents, because you’re setting terms for everybody in the round. And unless, unbeknownst to me, she had done quite a few of these, or had people that had as a partner, which is usually what happens, the celebrity partners with the person with the business experience.” A Legacy of Tenacity and Vision From dot-com pioneer to solo venture capitalist, Ben Narasin’s story is one of resilience, discipline, and unwavering belief in the power of great ideas and exceptional founders. In a world obsessed with quick wins, Narasin stands out as a steady hand—someone who knows that true greatness is built over decades, not quarters. Get full access to Seantzu at seantzu.substack.com/subscribe [https://seantzu.substack.com/subscribe?utm_medium=podcast&utm_campaign=CTA_4]